z-logo
open-access-imgOpen Access
Downregulation of PD‑L1 via amide analogues of brefelamide: Alternatives to antibody‑based cancer immunotherapy
Author(s) -
Jing Zhang,
Osamu Yamada,
Shinya Kida,
Shinya Murase,
Toshio Hattori,
Yoshiteru Oshima,
Haruhisa Kikuchi
Publication year - 2020
Publication title -
experimental and therapeutic medicine
Language(s) - English
Resource type - Journals
eISSN - 1792-1015
pISSN - 1792-0981
DOI - 10.3892/etm.2020.8553
Subject(s) - jurkat cells , cancer immunotherapy , immunotherapy , cancer research , downregulation and upregulation , oncogene , cancer cell , immune checkpoint , biology , cytotoxic t cell , immune system , pd l1 , chemistry , cell cycle , apoptosis , cancer , t cell , biochemistry , immunology , in vitro , gene , genetics

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom